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ABSTRACT
Objective: To update the Cochrane systematic review
of exercise-based cardiac rehabilitation (CR) for heart
failure.
Methods: A systematic review and meta-analysis of
randomised controlled trials was undertaken.
MEDLINE, EMBASE and the Cochrane Library were
searched up to January 2013. Trials with 6 or more
months of follow-up were included if they assessed the
effects of exercise interventions alone or as a
component of comprehensive CR programme
compared with no exercise control.
Results: 33 trials were included with 4740
participants predominantly with a reduced ejection
fraction (<40%) and New York Heart Association class
II and III. Compared with controls, while there was no
difference in pooled all-cause mortality between
exercise CR with follow-up to 1 year (risk ratio (RR)
0.93; 95% CI 0.69 to 1.27, p=0.67), there was a trend
towards a reduction in trials with follow-up beyond
1 year (RR 0.88; 0.75 to 1.02, 0.09). Exercise CR
reduced the risk of overall (RR 0.75; 0.62 to 0.92,
0.005) and heart failure-specific hospitalisation (RR
0.61; 0.46 to 0.80, 0.0004) and resulted in a clinically
important improvement in the Minnesota Living with
Heart Failure questionnaire (mean difference: −5.8
points, −9.2 to −2.4, 0.0007). Univariate meta-
regression analysis showed that these benefits were
independent of the type and dose of exercise CR, and
trial duration of follow- up, quality or publication date.
Conclusions: This updated Cochrane review shows
that improvements in hospitalisation and health-related
quality of life with exercise-based CR appear to be
consistent across patients regardless of CR programme
characteristics and may reduce mortality in the longer
term. An individual participant data meta-analysis is
needed to provide confirmatory evidence of the
importance of patient subgroup and programme level
characteristics (eg, exercise dose) on outcome.
INTRODUCTION
People with heart failure (HF) experience
marked reductions in their exercise capacity
which has detrimental effects on their activities
of daily living, health-related quality of life, and
ultimately their hospital admission rate and
mortality.1 While survival after HF diagnosis
has improved, HF has a poor prognosis— 30–
40% of patients diagnosed with HF die within
a year.2 It is estimated that the total annual cost
of HF to the UK National Health Service is cur-
rently around £1 billion or around 2% of the
total UK health budget; approximately, 70% of
this total is due to the costs of hospitalisation.3 4
Admissions due to HF are projected to rise by
50% over the next 25 years, largely due to
ageing of the population.4 A meta-analysis
reported a mortality of 32% in HF with pre-
served ejection fraction (HFPEF; ejection frac-
tion of >35–50%) versus 41% mortality in HF
with reduced ejection fraction (HFREF; rela-
tive risk (RR) 0.79) over an average of
47 months follow-up.5 Although individuals
with HFPEF contribute more than half (54%)
of all patients with HF, most trials to date have
recruited only patients with HFREF.6
Based on evidence, including the previous
2010 Cochrane review,7 The American College
of Cardiology/American Heart Association,
European Society of Cardiology, and National
Institute for Health and Care Excellence
(NICE) consistently recommend exercise-
based cardiac rehabilitation (CR) as an effect-
ive and safe adjunct in the management of
HF.4 8 9 The majority of randomised controlled
trials (RCTs) included in the 2010 Cochrane
review were in males at low-to-medium risk
(New York Heart Association (NYHA) class II
and III) and no trials including HFPEF.7
The aim of this updated Cochrane review
was to reassess the effectiveness of exercise-
based CR on mortality, hospital admissions,
morbidity and health-related quality of life of
patients with HF. We also sought to explore
how these effects may vary across differing
modes of exercise CR delivery.
METHODS
We conducted and reported this systematic
review in accordance with the PRISMA
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(Preferred Reporting Items for Systematic Reviews and
Meta-Analyses) statement.10
Data sources and searches
The following databases were searched from January
2008 (the searching end date of the previous Cochrane
review10) up to January 2013: Cochrane Central Register
of Controlled Trials (CENTRAL), MEDLINE, MEDLINE
In-Process, EMBASE, CINAHL and PsycINFO.
Conference proceedings were searched on Web of
Science. Trial registers (Controlled-trials.com and
Clinicaltrials.gov) were also checked. Further trials were
retrieved through a manual search of references from
published included studies and recent reviews. Search
filters were restricted to RCTs with no language restric-
tion. A copy of the search strategy is available (see
e-supplement).
Study selection
Studies were eligible if they were RCTs that included
adult (≥18 years) patients with HFPEF or HFREF, and
reported follow-up for 6 months or more postrandomisa-
tion. Trials in which participants had previously received
exercise-based CR were excluded. The intervention
group should receive exercise training either alone or as
a component of the comprehensive CR programme (ie,
health education and/or psychological intervention in
addition to exercise training). The control group must
not undergo any form of exercise training but may
receive active interventions (eg, education or psycho-
logical intervention) including usual medical care. Four
categories of outcome were sought: (1) mortality (all-
cause, HF-related and sudden death); (2) hospital
admission or rehospitalisation (all-cause or HF-related);
(3) health-related quality of life assessed by a validated
outcome measure (eg, Short-Form 36, Minnesota Living
with Heart Failure questionnaire); and (4) costs and
cost-effectiveness.
Two reviewers (VAS or EJD, and RST) independently
screened all titles and abstracts for eligibility. We
obtained full-text copies of papers and contacted
authors for more information when there was any uncer-
tainty. Any disagreements about inclusion of studies
were resolved by discussion.
Data extraction and risk of bias assessment
The following information categories were extracted
from included studies: study design, participant
characteristics, intervention group details (including
type frequency, duration and intensity of the exercise
and cointervention received), nature of control group,
length of follow-up and outcomes. We assessed trial
quality using the Cochrane risk of bias tool.11 Study
authors were contacted to seek clarification on issues of
reporting, missing data or to obtain further outcome
details. Data extraction and risk of bias assessment was
undertaken initially by a single reviewer (VAS or EJD)
using a standardised form and then verified by a second
reviewer (RST), and any disagreements about interpret-
ation of data was resolved by discussion.
Statistical analysis
Data were analysed in accordance with the Cochrane
Handbook for Systematic Reviews of Interventions.11
Dichotomous outcomes were expressed as RRs and 95%
CIs. For continuous outcomes, we sought the mean
change and SD in outcome between baseline and
follow-up for both exercise and control groups, and
when not available, the absolute mean (and SD)
outcome at follow-up for both groups was used. We cal-
culated mean difference (MD) or standardised MD
(SMD), and 95% CI for each study. Heterogeneity
between studies was assessed qualitatively (by comparing
the characteristics of included studies) and quantitatively
(using the I2 statistic). The results from included studies
were combined for each outcome to give an overall esti-
mate of the treatment effect where appropriate.
A fixed-effect model meta-analysis was used except
where statistical heterogeneity was identified (I2 statistic
>50%) and a random-effect model used.
We explored the potential heterogeneity in the effect of
exercise-based CR by two approaches: (1) within trial: sub-
group analyses (supported by subgroup×treatment group
interaction term), and (2) between trial: metaregression.
Metaregression was used to examine the association
between the effect of exercise on all-cause mortality, all-
cause hospitalisation and health-related quality of life up
to 12 months (as these three outcomes contained the
most trials). Specific study level covariates included in
meta-regression analyses included: dose of aerobic exer-
cise (calculated as the overall number of weeks of training
multiplied by the average number of sessions per week
multiplied by the average duration of sessions in minutes);
type of exercise (aerobic training alone or aerobic plus
resistance training); setting (hospital only, home only, or
both hospital and home); type of rehabilitation (exercise
only or comprehensive); overall risk of bias (‘low’, ie,
absence of bias in ≥5 of 8 of the risk of bias items or
‘high’—absence of bias in <5 of 8 of the risk of bias items);
single or multicentre; and publication date. Given the rela-
tively small ratio of trials to covariates, metaregression was
limited to univariate analysis and run using the STATA
permute option.11 Funnel plots and Egger tests were used
to assess potential small study effects and publication bias
for those outcomes with an adequate number of trials.12
All statistical analyses were performed using RevMan V.5.2
and STATAV.13.0.
RESULTS
Identification and selection of studies
Our searches yielded 8746 titles. Following the review of
titles and abstracts, we included 41 full papers. Eighteen of
these papers were excluded resulting in 14 RCTs
(23 papers) meeting the review inclusion criteria. The pre-
vious 2010 Cochrane review 2010 provided 19 RCTs
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(23 papers) giving an overall total of 33 included RCTs
(46 papers; citations available, see e-supplementary II13–58).
Figure 1 summarises the study selection process. Two trials
were each split into two subcomparisons as both rando-
mised patients to two different exercise interventions.26 44
Description of included trials
The 33 trials randomised a total of 4740 patients predomin-
antly with HFREF and NYHA class II and III (see table 1).
Detailed study characteristics are available (see
e-supplement). Four more recent trials included a
(undefined) number of patients with HFPEF.22 26 49 54 The
majority of trials were small (26 trials <100 participants)
and single centre (30 trials), with 1 large trial
(HF-ACTION 2009) contributing approximately 50%
(2331 participants) of all included patients.33–39 The mean
age of patients across the trials ranged from 51 to 81 years.
Although there was evidence of more females recruited in
recent trials, the majority of patients were predominantly
male (median 87%). Eleven trials reported follow-up in
excess of 12 months.13 16 18 22 35 46–49 54 Details of interven-
tion and control were often poorly reported. All trials eval-
uated an aerobic intervention and 11 also included
resistance training.13 20 23 40 41 45 46 50 56 57 Exercise training
was most commonly delivered in either an exclusively
centre-based setting or a centre-based setting in combin-
ation with some home exercise sessions. Five studies
were conducted in an exclusively home-based
setting.23 26 40 52 54 The dose of exercise training ranged
widely across studies with session duration of 15–120 min,
1–7 sessions/week, intensity of 40–80% of maximal heart
rate (or equivalent of 50–85% of maximal oxygen uptake
(VO2 max) or Borg rating of 12–18), and delivered over a
duration of 15–120 weeks.
Figure 1 Summary of study inclusion/exclusion process.
Table 1 Selected characteristics of the 33 included trials
Characteristic
Number (%) or
median (range)
Exercise-only CR 10 (30)
Setting
Centre-based 14 (43)
Home-based 5 (15)
Both 13 (39)
Unspecified 1 (3)
Sample size 52 (19–2331)
Publication date
1990–1999 5 (15)
2000–2009 22 (66)
2010 or later 6 (18)
Single centre 30 (91)
Study location
Europe 20 (60)
North America* 11 (33)
Other 2 (6)
Sex
Men only 12 (36)
Women only 0 (0)
Both 20 (61)
Unspecified 1 (3)
Age (years) 60.5 (51–81)
Diagnosis
HFREF only 29 (88)
HFPEF only 0 (0)
Both 4 (12)
Left ventricular ejection fraction (%) 29 (21–41)
Included NYHA IV 6 (18)
Unspecified 4 (12)
*HF-ACTION trial also included six French centres (out of 82
centres): +median of study means.
CR, cardiac rehabilitation; HFPEF, heart failure with preserved
ejection fraction; HFREF, heart failure with reduced ejection
fraction; NYHA, New York Heart Association.
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Risk of bias
A number of trials (particularly those published prior to
2000) failed to give sufficient details to allow complete
assessment of their potential risk of bias (table 2).
However, where details were reported, the overall risk of
bias of included studies was judged as moderate. Only 6
trials provided an adequate description of the random-
isation process.13 20 35 40 46 58 Nevertheless, none of the
studies had imbalance in baseline characteristics.
Although not always explicitly stated, most studies
appeared to perform intention-to-treat analysis, compar-
ing exercise and control group according to initial
random allocation. Given the nature of interventions, it
was not possible to blind the participants and care-givers,
though a number of studies did report blinding of
outcome assessment.22 26 35 45 46 49 55 58 We found no
evidence of selective outcome reporting. Some studies
may be prone to performance bias as they failed to
report cointervention details for both exercise and
control groups.16 27 28 30 42 43 46 49 53 Only two studies
failed to report losses to follow-up or drop-out rates.19 55
Outcomes
Mortality
There was no significant difference in pooled mortality
up to 12 months follow-up between exercise training
and control groups (25 trials, fixed-effect RR 0.92, 95%
CI 0.67 to 1.26, p=0.67; I2=0%, figure 2A). There was a
trend towards a reduction in all-cause mortality when
pooled across longest follow-up point of the six trials
with more than 12 months follow-up (fixed-effect RR
0.80, 95% CI 0.75 to 1.02; p=0.09; I2=34%, figure 2B).
Few studies consistently reported deaths due to HF or
sudden death.
Hospital admissions
There were reductions in the number of patients experi-
encing all hospital admissions with exercise compared
Table 2 Risk of bias assessment of included studies
Author (year)
Adequate
sequence
generation
Allocation
concealment
Outcome
blinding
Intention-to-
treat analysis
Groups
balanced
at baseline
Complete
outcome
reported
Austin (2005) √ √ X √ √ √
Belardinelli (1999) ? ? ? ? √ √
Belardinelli (2012) ? ? ? √ √ √
Bocalini (2008) ? ? ? X √ √
DANREHAB (2008) √ √ √ √ √ √
Davidson (2010) √ ? √ √ √ √
Dracup (2007) ? ? ? √ √ √
Gary (2010) ? ? √ √ √ √
Giannuzzi (2003) ? ? ? √ √ √
Gielen (2003) ? ? ? √ √ √
Gottleib (1999) ? ? ? ? √ √
Hambrecht (1995) ? ? ? ? √ √
Hambrecht (1998) ? ? ? √ √ √
Hambrecht (2000) √ ? ? √ √ √
HF-ACTION (2009) √ √ √ √ √ √
Jolly (2009) √ √ X √ ? √
Jónsdóttir (2006) ? ? ? √ √ √
Keteyian (1996) ? ? ? √ √ √
Kletcha (2007) ? ? ? ? √ √
Klocek (2005) ? ? ? ? √ √
Koukouvou (2004) ? ? √ ? √ √
McKelvie (2002) √ √ √ ? √ √
Mueller (2007) ? ? ? ? √ √
Myers (2000) ? ? ? √ √ √
Nilsson (2008) ? ? √ √ √ √
Normal (2012) ? ? X √ √ √
Passino (2006) ? ? ? ? √ √
Pozehl (2007) ? ? ? ? √ √
Wall (2010) ? ? ? √ √ √
Willenheimer (2001) ? ? √ ? √ √
Witham (2005) √ ? √ √ √ √
Witham (2012) √ √ ? √ √ √
Yeh (2011) √ ? √ √ √ √
√, risk of bias criteria met; X, risk of bias criteria not met; ?, inadequate reporting to assess risk of bias criteria.
HF, heart failure.
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with control up to 12 months follow-up (15 trials,
fixed-effect RR 0.75, 95% CI 0.62 to 0.92; p=0.005;
I2=0%, figure 3A) and HF-specific admissions (12 trials,
fixed-effect RR 0.61, 95% CI 0.46 to 0.8, p=0.0004;
I2=34%, figure 3C).There was no difference in all hos-
pital admissions in trials with more than 12 months
follow-up (5 trials, random-effect RR 0.92, 95% CI 0.66
to 1.29, p=0.63; I2=63%, figure 3B).
Health-related quality of life
A total of 18 trials reported a validated health-related
quality of life measure. While majority of studies (13
studies) used the disease-specific Minnesota Living with
Heart Failure questionnaire, the HF-ACTION trial used
Kansas City Cardiomyopathy Questionnaire.33 Generic
health-related quality of life was assessed using the
EuroQoL, Short-Form 36, Psychological General
Wellbeing index, Patient’s Global Assessment of Quality
of life and Spritzer’s Quality of Life Index. Eleven of 18
trials (61%) reported superior health-related quality of
life at follow-up in the exerciser group compared with
controls and in no case was health-related quality of life
score lower with exercise than control (table 3). Across
the studies reporting the total Minnesota Living with
Heart Failure questionnaire score up to 12 months
follow-up, there was evidence of a clinically important
improvement with exercise (random-effect MD −5.8,
95% CI −9.2 to −2.4; p=0.0007; I2=70%, figure 4A).
This benefit was also seen in the three trials that
reported follow-up of more than 12 months
(random-effect MD −9.5, 95% CI −17.5 to −1.5; p=0.022;
I2=73%, figure 4B). Pooling across all studies, regardless
Figure 2 (A) Pooled all cause mortality for trials up to 12 months follow up. (B) Pooled all cause mortality for trials with more
than 12 months follow up.
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of outcome measure used, showed a significant improve-
ment in quality of life with exercise (random-effect SMD
−0.46, 95% CI −0.66 to −0.26; p<0.0001; I2=79%, figure
4C). Where studies reported more than one
health-related quality of life measure score, we randomly
selected a single score for meta-analysis to prevent
double counting of a study. The inference of our analysis
did not change when we selected an alternative
health-related quality of life score.
Cost and cost-effectiveness
Three studies reported economic data, two undertaking
a formal cost effectiveness analysis17 37 and one reported
costs57 (see e-supplementary table). Based on the
Belardinelli trial, Georgiou et al17 estimated an add-
itional mean healthcare cost in the training group com-
pared with controls of US$3227/patient. Using
exponential survival modelling to 15.5 years, the esti-
mated increment in life expectancy with exercise was
Figure 3 (A) Pooled all hospitalisations up to 12 months follow up. (B) Pooled all hospitalisations more than 12 months follow
up. (C) Pooled heart failure hospitalisations.
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Table 3 Health-related quality of life results
Trial first author (year) Follow-up Measure
Outcome values (or change from baseline) at follow-up
Mean (SD)
Control versus exercise, between group p value Between-group difference
Austin (2005) 6 months MLWHF
Physical 20.4 (12.2) vs 12.6 (9.7) p<0.0001* Exercise>control
Emotional 8.0 (7.1) vs 4.4 (10.4) p<0.01* Exercise>control
Total 36.9 (24.0) vs 22.9 (17.8) p<0.001* Exercise>control
EQ-5D 0.58 (0.19) vs 0.70 (0.16) p<0.0001* Exercise>control
5 years MLWHF
Physical 19.3 (23.5) vs 18.3 (11.2) p=0.66* Exercise=control
Emotional 7.6 (7.1) vs 7.4 (6.5) p=0.88* Exercise=control
Total 37.1 (24.9) vs 35.5 (21.7) p=0.72* Exercise=control
EQ-5D 0.58 (0.22) vs 0.64 (0.19) p=0.12* Exercise=control
Bellardinelli (1999) 15 months MLWHF total 52 (20) vs 39 (20) p<0.001 Exercise>control
29 months 54 (22) vs 44 (21) p<0.001 Exercise>control
DANREHAB (2008) 12 months SF-36
PCS 37.4 (11.4) vs 42.7 (9.1)* p=0.14 Exercise=control
MCS 50.5 (10.0) vs 49.7 (8.8)* p=0.81 Exercise=control
Davidson (2010) 12 months MLWHF total 56.4 (18.3) vs 52.9 (15.7) p=0.33 Exercise=control
Dracup (2007) 6 months MLWHF
Physical 19.4 (11.5) vs 16.1 (10.0) p=0.04* Exercise>control
Emotional 10.5 (7.4) vs 7.8 (6.6) p=0.01* Exercise>control
Total 43.2 (26.5) vs 35.7 (23.7) p=0.05 Exercise>control
Gary (2010) Comp 6 months MLWHF total 34.3 (23.6) vs 24.2 (16.3) p=0.18* Exercise=control
Gary (2010) Exer 6 months MLWHF total 28.9 (29.9) vs 25.6 (19.7) p=0.71* Exercise=control
Gottlieb (1999) 6 months MLWHF
Total NR (NR) vs 22 (20) NR NR
MOS
PF NR (NR) vs 68 (28) NR NR
RL NR (NR) vs 50 (42) NR NR
GH NR (NR) vs 361 (224) NR NR
HF-ACTION (2009) 3 months KCCQ+ 5.21 (95% CI 4.42 to 6.00) vs 3.28 (2.48 to 4.09) p<0.001 Exercise>control
Jolly (2009) 6 months MLWHF total 34.5 (24.0) vs 36.3 (24.1) p=0.30 Exercise=control
EQ-5D 0.62 (0.32) vs 0.66 (0.24) p=0.004 Exercise>control
MLWHF total 34.9 (24.8) vs 37.6 (21.0) p=0.80 Exercise=control
12 months EQ-5D 0.69 (0.28) vs 0.68 (0.21) p=0.07 Exercise=control
Jónsdóttir (2006) 6 months Icelandic quality of life
questionnaire
4.10 (14.04) vs 47.55 (8.7) p=0.34 Exercise=control
Klocek (2005) 6.5 months PGWB total 99.0 vs 109.0 (training grp constant) vs
71.7 (training grp progressive) p<0.01
Exercise>control
Koukouvou (2004) 6 months MLWHF total 34.1 (13.0) vs 45.1 (9.9) p=0.05* Exercise>control
Spritzer QLI total 7.1 (1.1) vs 9.1 (1.1) p<0.0001* Exercise>control
McKelvie (2002) 12 months MLWHF total+ −3.3 (13.9) vs −3.4 (18.1) p=0.98 Exercise=control
Continued
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1.82 years/person compared with patients in the control
group and an incremental cost-effectiveness ratio of US
$1773/life-year saved. The HF-ACTION group estimated
a small mean gain in quality-adjusted life-years of 0.03 at
an additional mean cost of US$1161/patient at 2.5 years
follow-up.37 Witham et al57 reported the mean cost in
the exercise group were lower (£477.85/patient) than
the control group at 6 months follow-up. This cost differ-
ence was primarily the result of a reduction in the days
of hospital admission in the exercise group compared
with controls. None of the between group differences in
costs or outcomes across these three studies achieved
statistical significance at the p≤0.05 level.
Exploration of heterogeneity
There were no significant associations in univariate
metaregression for all-cause mortality, all hospitalisation
and health-related quality of life with the exception of
risk of bias and the setting for health-related quality of
life (table 4). The mean effect size for studies with a
higher risk of bias was larger than that for studies with
lower risk of bias (Minnesota Living with Heart Failure
MD: high risk −14.4 vs low risk −4.2, p=0.04): and
higher for single centre studies (all health-related
quality of life measures SMD: single centre −0.90 vs mul-
ticentre −0.35, p=0.04).
Although, a number of studies reported that they had
undertaken subgroup analyses, the methods used were
often unclear (see e-supplementary table). Only the
large HF-ACTION trial stated they performed a prede-
fined interaction test of differences in intervention
effects between subgroups. The HF-ACTION authors
reported no evidence of difference in the intervention
effects as assessed on either the primary outcome (all-
cause mortality or hospitalisation) or health-related
quality of life (Kansas City Cardiomyopathy
Questionnaire overall score) across a number of patient-
defined subgroups.34 35 37 A post hoc analysis by the
HF-ACTION group showed that a minimum volume of
exercise (3–7 metabolic equivalent-hours per week)
needed to be undertaken by patients for them to
achieve a clinical benefit.34
Small study bias
There was no evidence of funnel plot asymmetry for all-
cause mortality (Egger test p=0.805, e-supplementary
figure) or Minnesota Living with Heart Failure (Egger
test p=0.606, e-supplementary figure). The funnel plots
for SMD health-related quality of life showed evidence
of asymmetry (Egger test p<0.0001, e-supplementary
figure).
DISCUSSION
This systematic review shows that when compared to the
no-exercise control, exercise interventions alone or as a
component of comprehensive CR programme does not
reduce or increase short-term (up to 12 months
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follow-up) all-cause mortality. We saw reductions in the
risk of hospitalisation due to HF (RR reduction: 25%,
95% CI 8% to 38%) and improvements in health-related
quality of life following exercise interventions. In trials
reporting the Minnesota Living with Heart Failure ques-
tionnaire, those undertaking exercise were on an
average 5.8 points higher than controls. A difference of
four points or larger on the Minnesota Living with
Heart Failure questionnaire has been shown to repre-
sent a clinically important, meaningful difference for
patients.59 While the majority of included participants in
this review were HFREF and NYHA class II and III,
recent trials have recruited those who with HFPEF and
NHYA IV, and a greater proportion of females and older
patients. We found the benefits of exercise-CR appear to
be independent of type of exercise CR (exercise only vs
comprehensive CR, aerobic exercise only vs aerobic and
resistance exercise, average dose of exercise interven-
tion), and trial characteristics (ie, length of follow-up,
overall risk of bias, publication date).
Figure 4 (A) Pooled Minnesota Living with Heart Failure score up to 12 months follow up. (B) Pooled Minnesota Living with
Heart Failure score more than 12 months follow up (C) All quality of life scores up to 12 months follow up.
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Many trials included in this review have been con-
ducted in the era of contemporary medical therapy for
HF. For example, in the large multicentre HF-ACTION
trial, 94% of patients were receiving β-blockers and
angiotensin-receptor blocker or ACE inhibitors, and
45% had an implantable cardioverter defibrillator or
implanted biventricular pacemaker at the time of enrol-
ment.35 Given the proven survival advantage of these
medical treatments, it might be expected that any incre-
mental all-cause mortality benefit with exercise is likely
to be small. Nevertheless, there was a trend (p=0.09)
towards a reduction in all-cause mortality with exercise
training in the six trials reporting outcomes beyond
12 months.
The improvements in health-related quality of life with
exercise training seen in this review are in accordance
with the previous systematic review of van Tol et al60 but
not with that of Chien et al,61 which focused on home-
based exercise training and concluded that exercise
training compared with usual care did not improve the
health-related quality of life of patients with HF.
However, the review by Chien et al was limited to three
trials in 198 patients. Our metaregression analysis
showed no difference in the magnitude of the reduction
in hospitalisations and improvement in health-related
quality of life with exercise training in those studies
based in a hospital setting compared with those based in
a home setting.
Study limitations
The general lack of reporting of methods in the
included RCT reports made it difficult to assess their
methodological quality and thereby, judge their risk of
bias. There appeared to be improvement in the quality
of reporting in recent trials. Funnel plot asymmetry for
health-related quality of life outcomes indicated evi-
dence of small study bias and therefore, possible publi-
cation bias. Future trials need to also provide fuller
details of the interventions and controls in accordance
with Consolidated Standards of Reporting Trials
(CONSORT) extension for trials assessing non-
pharmacological treatments.62 A specific goal of this
update review was to clarify the impact of exercise train-
ing programmes on clinical events; many included trials
were relatively small and of short-term follow-up so that
the number of deaths and hospitalisations reported by
the majority of trials was small. The majority of trials
reported low numbers of deaths and hospitalisations.
There was evidence of larger treatment effect for
health-related quality of life outcomes in studies judged
to be at higher risk of bias compared with lower risk of
bias studies, suggesting that risk of bias may be a major
driver of the substantive statistical heterogeneity seen
across trials in this outcome. The majority of trials in
this review have investigated exercise training as a single
intervention and against a no-exercise control. However,
in practice, exercise-based CR is often an adjunct to
other HF management interventions, such as specialist
HF nurse support or disease management programmes.
While trials have demonstrated the benefits of such HF
management interventions alone, few trials have com-
pared such interventions with and without adding a
structured exercise training programme.63 19 This is an
important question for the future design of HF services
because the addition of an exercise CR programme can
add considerably to staffing and equipment costs. An
individual participant data meta-analysis (ExTraMATCH
II), using the RCTs identified in this review, is currently
underway to clarify the patient and intervention
characteristics that may drive variation in outcomes with
exercise-based CR for HF.64
In conclusion, this updated Cochrane review shows
that improvements in hospitalisation and health-related
quality of life with exercise-based CR appear to be con-
sistent across both patients with HF regardless of type of
CR programme and may reduce mortality in the longer
term. Individual participant data meta-analysis is needed
to provide confirmatory evidence of the importance of
patient subgroup and exercise programme character-
istics on outcomes.
In addition to improving the quality of reporting,
future clinical trials of exercise-based interventions in
Table 4 Univariate metaregression results
All-cause
mortality
p Value
All
hospitalisations
p Value
MLWHF
p Value
All HRQoL
outcomes
p Value
Type of rehabilitation (exercise only vs comprehensive) 0.76 0.77 0.23 0.28
Type of exercise (aerobic training alone vs aerobic plus resistance
training)
0.74 0.56 0.28 0.54
Exercise dose (number of weeks×number of sessions/week×average
duration of session in hours)
0.15 0.80 0.15 0.28
Exercise setting (hospital only, home only, both hospital and home) 0.23 0.11 0.85 0.23
Single versus multicentre 0.94 0.70 0.14 0.01
Publication date 0.54 0.54 0.46 0.60
Risk of bias* 0.40 0.57 0.04 0.08
*‘Low’ risk of bias trial: absence of bias in >5 out 8 of risk of bias items vs ‘high’ risk of trial: absence of bias in <5 out 8 items.
HRQoL, health-related quality of life; MLWHF, Minnesota Living with Heart Failure questionnaire.
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HF need to consider the generalisability of trial popula-
tions (women, older people and people with HFPEF
remain under-represented in trial populations) and
interventions to enhance the long-term maintenance of
exercise-based CR programmes, as well as the outcomes,
costs and cost-effectiveness of programmes delivered
exclusively in a home-based setting.
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